Lv0
0 积分 2026-03-29 加入
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
3个月前
已完结
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
3个月前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
3个月前
已完结
CAR T cells produced in vivo to treat cardiac injury
4个月前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
5个月前
已完结
皖公网安备34019202002308
